T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
ADT
ADT
$5.46B
| $28.9M | ﹤0.01% |
3,627,682
-13,275
| -0.4% | -$85.8K |
|
1027
Main Street Capital
MAIN
$5.54B
| $28.9M | ﹤0.01% |
928,521
-20,624
| -2% | -$581K |
|
1028
First Hawaiian
FHB
$3.39B
| $28.9M | ﹤0.01% |
1,675,178
+524,364
| +46% | +$8.8M |
|
1029
Arvinas
ARVN
$589M
| $28.8M | ﹤0.01% |
859,025
+716,226
| +502% | +$30.4M |
|
1030
Quest Diagnostics
DGX
$26.1B
| $28.8M | ﹤0.01% |
252,372
-18,495
| -7% | -$1.96M |
|
1031
Omnicom Group
OMC
$24.2B
| $28.7M | ﹤0.01% |
525,185
-40,310
| -7% | -$2.19M |
|
|
GNMK
1032
DELISTED
GenMark Diagnostics, Inc
GNMK
| $28.6M | ﹤0.01% |
1,945,978
-174,069
| -8% | -$1.77M |
|
1033
Cencora
COR
$59.2B
| $28.5M | ﹤0.01% |
283,008
-20,075
| -7% | -$1.85M |
|
1034
HEICO Corp Class A
HEI.A
$38.1B
| $28.5M | ﹤0.01% |
350,988
-406,660
| -54% | -$31.5M |
|
|
LL
1035
DELISTED
LL Flooring Holdings, Inc.
LL
| $28.5M | ﹤0.01% |
2,053,914
+36,773
| +2% | +$312K |
|
1036
JD.com
JD
$39.6B
| $28.4M | ﹤0.01% |
472,740
+445,440
| +1,632% | +$22.6M |
|
1037
Intellia Therapeutics
NTLA
$1.66B
| $28.4M | ﹤0.01% |
+1,353,314
| New | +$23M |
|
1038
CAE Inc. Common Shares
CAE
$8.47B
| $28.2M | ﹤0.01% |
1,746,540
-39,211
| -2% | -$607K |
|
1039
Oneok
OKE
$58.4B
| $28M | ﹤0.01% |
842,974
-22,331
| -3% | -$728K |
|
1040
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
| $28M | ﹤0.01% |
+990,884
| New | +$28.6M |
|
1041
American Vanguard Corp
AVD
$62.8M
| $27.9M | ﹤0.01% |
2,030,479
+403
| +0% | +$5.41K |
|
1042
ADC Therapeutics
ADCT
$134M
| $27.7M | ﹤0.01% |
+592,251
| New | +$22.5M |
|
1043
Healthpeak Properties
DOC
$14.3B
| $27.7M | ﹤0.01% |
1,005,773
+24,165
| +2% | +$617K |
|
1044
Graphic Packaging
GPK
$3.51B
| $27.6M | ﹤0.01% |
1,969,750
+687,464
| +54% | +$9.25M |
|
1045
Builders FirstSource
BLDR
$7.91B
| $27.5M | ﹤0.01% |
1,328,915
+1,251,490
| +1,616% | +$22.6M |
|
1046
Comfort Systems
FIX
$60.8B
| $27.4M | ﹤0.01% |
672,607
+53,001
| +9% | +$1.88M |
|
1047
Aaon
AAON
$7.23B
| $27.3M | ﹤0.01% |
753,627
-5,004
| -0.7% | -$168K |
|
|
BLD
1048
DELISTED
TopBuild
BLD
| $27.3M | ﹤0.01% |
239,607
+202,296
| +542% | +$20.2M |
|
|
RNAM
1049
DELISTED
Avidity Biosciences
RNAM
| $26.9M | ﹤0.01% |
+950,400
| New | +$27.4M |
|
1050
Ziff Davis
ZD
$1.92B
| $26.6M | ﹤0.01% |
484,543
+4,156
| +0.9% | +$272K |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.